HIGHLIGHTS
- who: Annarosa Floreani and Sara De Martin from the Institute for Research, Hospitalization and Healthcare, Negrar, Italy University of Padova, Padova, Italy have published the article: COVID-19 and Autoimmune Liver Diseases, in the Journal: (JOURNAL) of 11/03/2020
- what: The aim of this review is to provide an overview on the risk of SARS-CoV-2 in patients with autoimmune liver disease, also adding insights on the current use of the vaccines against COVID-19. This study demonstrated that 89% of patients seroconverted within four weeks post second dose whereas 11% of patients . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.